Raymond James Financial Services Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $9.51K | Sell |
10,507
-1,900
| -15% | -$1.72K | ﹤0.01% | 3394 |
|
|
2024
Q2 | $12.4K | Buy |
+12,407
| New | +$12.4K | ﹤0.01% | 3353 |
|
|
2022
Q1 | – | Sell |
-13,961
| Closed | -$34K | – | 3320 |
|
|
2021
Q4 | $34K | Sell |
13,961
-400
| -3% | -$974 | ﹤0.01% | 3190 |
|
|
2021
Q3 | $36K | Sell |
14,361
-2
| -0% | -$5 | ﹤0.01% | 3186 |
|
|
2021
Q2 | $41K | Buy |
14,363
+402
| +3% | +$1.15K | ﹤0.01% | 3195 |
|
|
2021
Q1 | $33K | Buy |
13,961
+1,886
| +16% | +$4.46K | ﹤0.01% | 3101 |
|
|
2020
Q4 | $21K | Sell |
12,075
-2,985
| -20% | -$5.19K | ﹤0.01% | 2927 |
|
|
2020
Q3 | $14K | Sell |
15,060
-1,144
| -7% | -$1.06K | ﹤0.01% | 2806 |
|
|
2020
Q2 | $14K | Buy |
+16,204
| New | +$14K | ﹤0.01% | 2751 |
|
|
2020
Q1 | – | Sell |
-19,860
| Closed | -$18K | – | 2630 |
|
|
2019
Q4 | $18K | Sell |
19,860
-22,781
| -53% | -$20.6K | ﹤0.01% | 2784 |
|
|
2019
Q3 | $42K | Sell |
42,641
-130
| -0.3% | -$128 | ﹤0.01% | 2702 |
|
|
2019
Q2 | $47K | Sell |
42,771
-4,297
| -9% | -$4.72K | ﹤0.01% | 2738 |
|
|
2019
Q1 | $62K | Buy |
47,068
+13,383
| +40% | +$17.6K | ﹤0.01% | 2679 |
|
|
2018
Q4 | $31K | Sell |
33,685
-39,833
| -54% | -$36.7K | ﹤0.01% | 2485 |
|
|
2018
Q3 | $151K | Buy |
73,518
+115
| +0.2% | +$236 | ﹤0.01% | 2597 |
|
|
2018
Q2 | $132K | Sell |
73,403
-5,715
| -7% | -$10.3K | ﹤0.01% | 2566 |
|
|
2018
Q1 | $186K | Buy |
79,118
+6,286
| +9% | +$14.8K | ﹤0.01% | 2278 |
|
|
2017
Q4 | $137K | Buy |
72,832
+38,131
| +110% | +$71.7K | ﹤0.01% | 2333 |
|
|
2017
Q3 | $86K | Buy |
34,701
+5,600
| +19% | +$13.9K | ﹤0.01% | 2398 |
|
|
2017
Q2 | $80K | Buy |
29,101
+1,258
| +5% | +$3.46K | ﹤0.01% | 2361 |
|
|
2017
Q1 | $84K | Buy |
27,843
+114
| +0.4% | +$344 | ﹤0.01% | 2269 |
|
|
2016
Q4 | $88K | Buy |
27,729
+11,727
| +73% | +$37.2K | ﹤0.01% | 2195 |
|
|
2016
Q3 | $55K | Hold |
16,002
| – | – | ﹤0.01% | 2187 |
|
|
2016
Q2 | $37K | Buy |
16,002
+1,143
| +8% | +$2.64K | ﹤0.01% | 2169 |
|
|
2016
Q1 | $37K | Buy |
+14,859
| New | +$37K | ﹤0.01% | 1958 |
|